On the recordFebruary 3, 2016
FDA approved the first biosimilar in March 2015 and is convening an advisory committee next week to consider a second application.
Source
congress.govFDA approved the first biosimilar in March 2015 and is convening an advisory committee next week to consider a second application.
Pitts discusses the FDA's progress on biosimilars since the first approval.
Share
More from Joe Pitts
Administrator Slavitt, CMS announced that APTC and CSR subsidies would be ended for 2016 enrollees who received APTCs in 2014 but did not reconcile these payments on their federal taxes.
We will hear from witnesses on ways to address our trauma and emergency medical systems.
I thank my colleague, Rep. Pete Olson, for sponsoring this important legislation which will be welcome news for the over 100,000,000 people afflicted with diabetes or pre-diabetes.
Today's hearing is an important discussion that will examine the areas where we can improve our national trauma system.